BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 27638681)

  • 1. Metastasectomy Following Immunotherapy with Adoptive Cell Transfer for Patients with Advanced Melanoma.
    Klemen ND; Feingold PL; Goff SL; Hughes MS; Kammula US; Yang JC; Schrump DS; Rosenberg SA; Sherry RM
    Ann Surg Oncol; 2017 Jan; 24(1):135-141. PubMed ID: 27638681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival Outcomes of Salvage Metastasectomy After Failure of Modern-Era Systemic Therapy for Melanoma.
    Li AT; Vakharia K; Lo SN; Varey AHR; Carlino MS; Saw RPM; Shannon KF; Howle JR; Pennington TE; Stretch JR; Nieweg OE; Spillane AJ; Long GV; Menzies AM; Scolyer RA; Thompson JF; Ch'ng S
    Ann Surg Oncol; 2021 Oct; 28(11):6109-6123. PubMed ID: 34347220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of relapse and response to retreatment in patients with metastatic melanoma or renal cell carcinoma who responded to interleukin-2-based immunotherapy.
    Lee DS; White DE; Hurst R; Rosenberg SA; Yang JC
    Cancer J Sci Am; 1998; 4(2):86-93. PubMed ID: 9532410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thoracic metastasectomy for adoptive immunotherapy of melanoma: a single-institution experience.
    Klapper JA; Davis JL; Ripley RT; Smith FO; Nguyen DM; Kwong KF; Mercedes L; Kemp CD; Mathur A; White DE; Dudley ME; Wunderlich JR; Rosenberg SA; Schrump DS
    J Thorac Cardiovasc Surg; 2010 Dec; 140(6):1276-82. PubMed ID: 20584535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metastasectomy for melanoma is associated with improved overall survival in responders to targeted molecular or immunotherapy.
    Medina BD; Choi BH; Rodogiannis KG; Moran U; Shapiro RL; Pavlick A; Osman I; Berman RS; Lee AY
    J Surg Oncol; 2020 Sep; 122(3):555-561. PubMed ID: 32441371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metastasectomy following incomplete response to high-dose interleukin-2.
    Hughes T; Broucek J; Iodice G; Bommareddy PK; Basu S; Kaufman HL
    J Surg Oncol; 2018 Mar; 117(4):572-578. PubMed ID: 29165819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metastatic melanoma to small bowel: metastasectomy is supported in the era of immunotherapy and checkpoint inhibitors.
    Wong P; Wisneski AD; Tsai KK; Chang TT; Hirose K; Nakakura EK; Daud AI; Maker AV; Corvera CU
    World J Surg Oncol; 2024 Mar; 22(1):77. PubMed ID: 38468341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adoptive transfer of tumor-infiltrating lymphocytes in patients with metastatic melanoma: intent-to-treat analysis and efficacy after failure to prior immunotherapies.
    Besser MJ; Shapira-Frommer R; Itzhaki O; Treves AJ; Zippel DB; Levy D; Kubi A; Shoshani N; Zikich D; Ohayon Y; Ohayon D; Shalmon B; Markel G; Yerushalmi R; Apter S; Ben-Nun A; Ben-Ami E; Shimoni A; Nagler A; Schachter J
    Clin Cancer Res; 2013 Sep; 19(17):4792-800. PubMed ID: 23690483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Adjuvant adoptive immunotherapy in patients with stage III and resected stage IV melanoma: a pilot study].
    Verdecchia GM; Ridolfi L; Ridolfi R; Riccobon A; Bertagni A; Vagliasindi A; Petrini M; Stefanelli M; Milandri C; Amadori D
    Tumori; 2003; 89(4 Suppl):298-300. PubMed ID: 12903626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors in metastatic melanoma patients treated with biochemotherapy and maintenance immunotherapy.
    Minor DR; Moore D; Kim C; Kashani-Sabet M; Venna SS; Wang W; Boasberg P; O'Day S
    Oncologist; 2009 Oct; 14(10):995-1002. PubMed ID: 19776094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-operative survival following metastasectomy for patients receiving BRAF inhibitor therapy is associated with duration of pre-operative treatment and elective indication.
    He M; Lovell J; Ng BL; Spillane J; Speakman D; Henderson MA; Shackleton M; Gyorki DE
    J Surg Oncol; 2015 Jun; 111(8):980-4. PubMed ID: 26080731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Surgery in Combination with Immunotherapy.
    Klemen ND; Shindorf ML; Sherry RM
    Surg Oncol Clin N Am; 2019 Jul; 28(3):481-487. PubMed ID: 31079801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical responses in a phase II study using adoptive transfer of short-term cultured tumor infiltration lymphocytes in metastatic melanoma patients.
    Besser MJ; Shapira-Frommer R; Treves AJ; Zippel D; Itzhaki O; Hershkovitz L; Levy D; Kubi A; Hovav E; Chermoshniuk N; Shalmon B; Hardan I; Catane R; Markel G; Apter S; Ben-Nun A; Kuchuk I; Shimoni A; Nagler A; Schachter J
    Clin Cancer Res; 2010 May; 16(9):2646-55. PubMed ID: 20406835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of early 18F-FDG PET/CT studies for treatment response evaluation to ipilimumab in metastatic melanoma: preliminary results of an ongoing study.
    Sachpekidis C; Larribere L; Pan L; Haberkorn U; Dimitrakopoulou-Strauss A; Hassel JC
    Eur J Nucl Med Mol Imaging; 2015 Mar; 42(3):386-96. PubMed ID: 25359635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up of patients with GIST undergoing metastasectomy in the era of imatinib -- analysis of prognostic factors (EORTC-STBSG collaborative study).
    Bauer S; Rutkowski P; Hohenberger P; Miceli R; Fumagalli E; Siedlecki JA; Nguyen BP; Kerst M; Fiore M; Nyckowski P; Hoiczyk M; Cats A; Casali PG; Treckmann J; van Coevorden F; Gronchi A
    Eur J Surg Oncol; 2014 Apr; 40(4):412-9. PubMed ID: 24491288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hepatic intra-arterial bio-chemotherapy for the treatment of melanoma patients with liver metastasis: a phase II clinical study].
    Cui CL; Chi ZH; Yuan XQ; Lian HY; Si L; Guo J
    Ai Zheng; 2008 Aug; 27(8):845-50. PubMed ID: 18710619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TA90 immune complex predicts survival following surgery and adjuvant vaccine immunotherapy for stage IV melanoma.
    Hsueh EC; Gupta RK; Qi K; Yee R; Leopoldo ZC; Morton DL
    Cancer J Sci Am; 1997; 3(6):364-70. PubMed ID: 9403050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maintenance biotherapy for metastatic melanoma with interleukin-2 and granulocyte macrophage-colony stimulating factor improves survival for patients responding to induction concurrent biochemotherapy.
    O'Day SJ; Boasberg PD; Piro L; Kristedja TS; Wang HJ; Martin M; Deck R; Ames P; Shinn K; Kim H; Fournier P; Gammon G
    Clin Cancer Res; 2002 Sep; 8(9):2775-81. PubMed ID: 12231516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Surgery in Stage IV Melanoma.
    O'Neill CH; McMasters KM; Egger ME
    Surg Oncol Clin N Am; 2020 Jul; 29(3):485-495. PubMed ID: 32482322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is there a role for pulmonary metastasectomy with a curative intent in patients with metastatic urinary transitional cell carcinoma?
    Matsuguma H; Yoshino I; Ito H; Goya T; Matsui Y; Nakajima J; Ikeda N; Okumura S; Shiono S; Nomori H;
    Ann Thorac Surg; 2011 Aug; 92(2):449-53. PubMed ID: 21801905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.